Examkin

Tüm alıştırma soruları

771 soru

Tüm türler4,736Çoktan seçmeli2,413Çoklu seçim567Sayısal127Eşleştirme858Sıralama771
Soru 1Soru →

A 28-year-old man presents to the clinic for a follow-up visit after testing positive for HIV last week. When the physician brings up the topic of starting antiretroviral therapy (ART), the patient immediately crosses his arms and says, 'I am not taking pills every day that will just make me sick and let everyone know I have this.' The physician decides to use the 'Elicit-Provide-Elicit' framework of motivational interviewing to counsel the patient.

Arrange the following physician statements in the most appropriate chronological sequence for this counseling encounter.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence follows the core principles of Motivational Interviewing (the Elicit-Provide-Elicit model): 1) Ask permission, 2) Elicit baseline understanding and concerns, 3) Provide tailored empathetic information, 4) Elicit the patient's response to the information, and 5) Formulate a collaborative plan.
The correct sequence minimizes resistance and maximizes patient autonomy. The physician first asks permission to engage in the topic, which lowers defenses. Next, eliciting baseline beliefs uncovers the specific barriers (in this case, fear of side effects and stigma). Only then should the physician provide targeted, validating information. Afterward, eliciting the patient's reaction ensures the information was understood and assesses readiness. Finally, a collaborative plan is made that aligns with the patient's current comfort level, ensuring continuity of care.

Adım Adım Çözüm

1
Ask permission to discuss the topic.
Patient agrees to the conversation on their own terms.
Decreases initial defensiveness and establishes a partnership.
2
Elicit the patient's current knowledge and fears.
Physician identifies the specific barriers (fear of side effects and stigma).
Prevents the physician from making assumptions and allows for targeted education.
3
Provide objective information with empathy.
Patient receives accurate medical facts about modern ART.
Addresses the specific misconceptions uncovered in the previous step.
4
Elicit the patient's interpretation of the provided facts.
Physician assesses if the patient's perspective has shifted.
Ensures the information was understood correctly and evaluates readiness to change.
5
Summarize and create a follow-up plan.
A safe, non-pressured next step is agreed upon.
Respects the patient's autonomy and current stage of change, keeping the therapeutic relationship intact.

Anahtar Kavram

Motivational Interviewing: The Elicit-Provide-Elicit Framework
Soru 2Soru →

A 58-year-old man with long-standing type 2 diabetes mellitus and peripheral neuropathy is evaluated in the clinic for a deep ulcer on the plantar aspect of his left foot. On examination, there is surrounding erythema and induration. A sterile metal probe reaches the deep fascia but does not definitively contact bone. Given the high clinical suspicion for underlying osteomyelitis, the physician decides to initiate a stepwise diagnostic imaging workup.

Arrange the following imaging modalities in the standard recommended sequence for evaluating suspected diabetic foot osteomyelitis, starting from the most appropriate initial test to the alternative advanced study reserved for patients with specific contraindications.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: 1) Plain radiography, 2) Magnetic resonance imaging (MRI), and 3) Radiolabeled leukocyte scan.
The standard diagnostic algorithm for suspected osteomyelitis begins with plain radiography to identify gross abnormalities or alternative diagnoses. When radiographs are nondiagnostic, MRI is the gold standard advanced imaging modality due to its high sensitivity for marrow edema. If MRI cannot be performed (e.g., due to an incompatible pacemaker), a radiolabeled leukocyte scan is the appropriate alternative advanced test.

Adım Adım Çözüm

1
Identify the initial imaging test for suspected osteomyelitis.
Plain radiography of the left foot.
It is widely available and rapidly rules out other gross pathologies like foreign bodies, fractures, or air in soft tissues, serving as a necessary baseline.
2
Determine the preferred advanced imaging modality when initial films are nondiagnostic.
Magnetic resonance imaging (MRI).
MRI is the most sensitive and specific modality for diagnosing early osteomyelitis, detecting bone marrow edema long before cortical changes appear on plain films.
3
Identify the modality reserved for when the preferred advanced test is contraindicated.
Radiolabeled leukocyte (white blood cell) scan.
This study is used when patients have MRI contraindications (such as incompatible pacemakers), as it specifically tags sites of active infection but lacks the high-resolution anatomical detail of an MRI.

Anahtar Kavram

The standard imaging sequence for suspected diabetic foot osteomyelitis begins with plain radiography, followed by MRI for definitive diagnosis, with radiolabeled leukocyte scans reserved for cases where MRI is contraindicated.
Soru 3Soru →

A 71-year-old man presents to the outpatient clinic with a 4-week history of progressively worsening yellowing of his skin and eyes, accompanied by generalized pruritus and a 6-kg (13-lb) unintentional weight loss. He reports that his urine has become dark like tea, and his stools are pale and clay-colored. He denies any abdominal pain, nausea, or vomiting. His medical history is significant for hypertension and type 2 diabetes mellitus. Physical examination reveals pronounced scleral icterus and a palpable, smooth, non-tender mass in the right upper quadrant of the abdomen. Laboratory studies show a total bilirubin of 14.2 mg/dL, direct bilirubin of 11.5 mg/dL, and an alkaline phosphatase of 780 U/L. The physician suspects a malignant biliary obstruction and initiates a diagnostic workup. Arrange the following imaging and image-guided modalities in the most appropriate chronological sequence for the evaluation of this patient's painless jaundice, proceeding from the initial diagnostic step to detailed staging and therapeutic intervention.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with Transabdominal right upper quadrant ultrasonography, followed by Triphasic contrast-enhanced computed tomography (CT) of the abdomen, then Endoscopic ultrasonography (EUS) with fine-needle aspiration, and concludes with Endoscopic retrograde cholangiopancreatography (ERCP) with fluoroscopy.
The optimal diagnostic sequence for suspected malignant biliary obstruction emphasizes minimizing patient risk while gathering necessary data. It begins with the least invasive modality, transabdominal ultrasonography, to confirm extrahepatic ductal dilation. Once dilation is confirmed, a pancreatic protocol CT is ordered for non-invasive disease staging and to localize the specific mass. Following accurate staging, endoscopic ultrasonography (EUS) is utilized to safely obtain a definitive tissue diagnosis via fine-needle aspiration. Finally, ERCP is performed primarily as a therapeutic maneuver to decompress the biliary tree via stenting, relieving the patient's severe jaundice prior to definitive surgery or palliative care.

Adım Adım Çözüm

1
Analyze the clinical presentation and physical examination findings.
The patient presents with painless jaundice, weight loss, and a palpable non-tender gallbladder (Courvoisier sign), which is highly indicative of a malignant periampullary or pancreatic head tumor causing biliary obstruction.
Establishing the most likely underlying pathophysiology dictates the urgency and pathway of the subsequent diagnostic imaging workup.
2
Determine the most appropriate initial imaging test.
Transabdominal ultrasonography is selected as the first step.
It is the standard first-line test for evaluating jaundice because it can quickly, non-invasively, and inexpensively confirm extrahepatic biliary dilation and confidently exclude choledocholithiasis.
3
Identify the best modality for non-invasive anatomical staging.
Triphasic contrast-enhanced abdominal CT (pancreatic protocol) is ordered next.
CT provides the necessary detailed cross-sectional anatomy to detect the primary mass, evaluate for locoregional vascular invasion (e.g., superior mesenteric artery/vein), and detect distant hepatic metastases.
4
Select modalities for tissue diagnosis and therapeutic intervention.
Endoscopic ultrasonography (EUS) with aspiration is performed, followed by Endoscopic retrograde cholangiopancreatography (ERCP).
EUS provides a highly sensitive and safe route for tissue biopsy of pancreatic lesions. Subsequently, ERCP is utilized to provide therapeutic biliary stenting to relieve the patient's symptomatic hyperbilirubinemia and pruritus.

Anahtar Kavram

The standard diagnostic imaging sequence for suspected malignant biliary obstruction progresses systematically from non-invasive confirmation of ductal dilation (Ultrasound) to cross-sectional staging (CT), followed by image-guided tissue sampling (EUS) and therapeutic decompression (ERCP).
Soru 4Soru →

A 32-year-old man presents to the clinic with episodic spells of severe, throbbing headaches, profuse sweating, and palpitations. These episodes have occurred weekly over the past month, lasting approximately 15 to 20 minutes before resolving spontaneously. He takes no medications and does not use illicit substances. His family history is notable for his father passing away suddenly at age 45 from a suspected stroke. On examination, the patient appears diaphoretic and anxious. His blood pressure is 185/110 mm Hg, heart rate is 115/min, and respiratory rate is 18/min. The remainder of the physical examination, including fundoscopy, is unremarkable. Pheochromocytoma is highly suspected.

Arrange the following diagnostic and evaluation steps in the most appropriate chronological sequence for this patient, from initial workup to final comprehensive evaluation.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: 1) Measurement of plasma fractionated free metanephrines, 2) Computed tomography (CT) of the abdomen and pelvis, 3) Gallium-68 DOTATATE positron emission tomography (PET), and 4) Germline genetic testing for susceptibility syndromes.
The evaluation of a suspected pheochromocytoma follows a rigid, stepwise clinical protocol. Initial testing must confirm catecholamine excess biochemically, typically with plasma fractionated free metanephrines or 24-hour urine fractionated metanephrines, due to their exceptionally high sensitivity. Once biochemical excess is confirmed, anatomical localization is performed with a CT or MRI of the abdomen and pelvis. Because this patient is young (< 40 years) and has a suspicious family history, there is an increased pre-test probability of hereditary, extra-adrenal, or multifocal disease; therefore, functional imaging (such as Gallium-68 DOTATATE PET or Iodine-123 MIBG scintigraphy) is indicated preoperatively. Finally, because up to 40% of pheochromocytomas and paragangliomas are associated with germline mutations (e.g., RET, VHL, NF1, SDHx), comprehensive genetic testing is the standard of care after the diagnosis is established.

Adım Adım Çözüm

1
Establish the biochemical diagnosis
Measurement of plasma fractionated free metanephrines
Highly sensitive biochemical confirmation of catecholamine excess is mandatory before any imaging to prevent false-positive diagnoses from highly prevalent adrenal incidentalomas.
2
Localize the primary tumor anatomically
Computed tomography (CT) of the abdomen and pelvis
Anatomical cross-sectional imaging determines the precise location and size of the catecholamine-secreting tumor, guiding subsequent functional imaging and surgical planning.
3
Evaluate for multifocal or metastatic disease
Gallium-68 DOTATATE positron emission tomography (PET)
In a young patient (32 years old) at high risk for hereditary syndromes and extra-adrenal disease, whole-body functional imaging is a critical preoperative step to ensure complete disease resection.
4
Identify hereditary syndromes
Germline genetic testing for susceptibility syndromes
Given the significant risk of associated familial syndromes (e.g., VHL, MEN2, SDHx), formal genetic evaluation is standard of care for long-term monitoring and screening of family members.

Anahtar Kavram

The diagnostic algorithm for suspected pheochromocytoma strictly proceeds from biochemical confirmation to anatomical localization, followed by functional imaging in high-risk patients, and concludes with genetic evaluation.
Tahmini Süre:1m 30s
Soru 5Soru →

A 42-year-old female presents to the clinic after noticing a painless lump in the anterior portion of her neck while swallowing. She has no symptoms of hyperthyroidism or hypothyroidism, and she denies any history of head or neck irradiation. Physical examination reveals a firm, mobile, 2.5-cm nodule in the right lobe of the thyroid gland. No cervical lymphadenopathy is appreciated. Laboratory testing shows a serum thyroid-stimulating hormone (TSH) level of 1.8 mIU/L (normal: 0.4-4.0 mIU/L). Arrange the following clinical interventions in the most appropriate chronological order for the definitive evaluation and management of this patient's condition, assuming findings at each step strongly suggest a primary differentiated thyroid malignancy.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: Thyroid ultrasound, followed by fine-needle aspiration, followed by total thyroidectomy, followed by radioactive iodine ablation, and finally lifelong levothyroxine suppression therapy.
The standard diagnostic and therapeutic cascade for a thyroid nodule in a euthyroid patient dictates evaluating structure before attempting tissue sampling. Therefore, an ultrasound is the first indicated step. Because the TSH is normal, a radionuclide uptake scan is bypassed. If the ultrasound reveals a solid nodule greater than 1 cm or highly suspicious features, an FNA biopsy is sequentially performed to secure a cytological diagnosis. Upon confirming malignancy, a total thyroidectomy is the definitive primary management. In the postoperative period, radioactive iodine ablation is commonly indicated to eradicate residual normal tissue or micrometastases. Finally, the patient must be maintained on lifelong levothyroxine, carefully dosed to suppress TSH and thus minimize the risk of tumor recurrence.

Adım Adım Çözüm

1
Evaluate the clinical presentation and initial laboratory findings.
The patient has a 2.5-cm thyroid nodule and is euthyroid (normal TSH).
A normal or elevated TSH indicates the nodule is not autonomously hyperfunctioning (a 'cold' nodule), which carries a higher risk of malignancy and requires immediate structural evaluation rather than a radionuclide scan.
2
Order the most appropriate initial imaging modality.
A dedicated thyroid ultrasound is performed.
Ultrasound accurately sizes the nodule and checks for suspicious sonographic patterns such as microcalcifications, hypoechogenicity, or irregular margins.
3
Obtain a definitive cytological diagnosis.
An ultrasound-guided fine-needle aspiration (FNA) biopsy is conducted.
Tissue sampling is necessary to differentiate between benign and malignant etiologies to dictate the extent of surgical intervention.
4
Execute the primary therapeutic and staging procedure.
A total thyroidectomy is performed.
For a confirmed malignancy >1 cm (such as papillary or follicular carcinoma), surgical resection is the standard of care to remove the primary tumor.
5
Administer adjuvant treatment to prevent recurrence.
Radioactive iodine (I-131) ablation is administered.
I-131 specifically targets and destroys remnant normal thyroid tissue and microscopic metastatic foci, which also facilitates future surveillance using thyroglobulin levels.
6
Establish a long-term maintenance and risk-reduction regimen.
Levothyroxine therapy is initiated.
Exogenous levothyroxine prevents clinical hypothyroidism and suppresses TSH secretion from the pituitary, removing a potent growth stimulus for any residual neoplastic cells.

Anahtar Kavram

The algorithmic workup of a euthyroid patient with a thyroid nodule requires sequential progression from non-invasive imaging (ultrasound) to minimally invasive diagnosis (fine-needle aspiration), followed by definitive resection (thyroidectomy), adjuvant ablation (radioactive iodine), and long-term hormonal suppression.
Tahmini Süre:1m 30s
Soru 6Soru →

A second-year internal medicine resident is cross-covering the intensive care unit overnight. A patient rapidly develops acute hypoxemic respiratory failure and requires emergent endotracheal intubation. The on-call critical care attending arrives to perform the procedure. As the attending picks up the laryngoscope and prepares to administer induction medications, the resident notices that the attending has a staggering gait, significantly slurred speech, and a strong odor of alcohol. According to ethical guidelines and professional standards regarding physician impairment, arrange the following required actions in the correct chronological sequence.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with immediate patient protection by halting the procedure, followed by securing alternate care, reporting to institutional leadership, and finally institutional referral to a Physician Health Program.
The correct sequence prioritizes immediate patient safety above all other concerns. When a physician is acutely impaired and about to perform a dangerous procedure, the first obligation is to stop the procedure to prevent harm. Once the immediate threat is neutralized, the patient's urgent medical needs must be met by finding a competent replacement. Only after the patient is stabilized should the observer escalate the situation to institutional leadership, who are then responsible for formal investigation and mandatory referral to a Physician Health Program.

Adım Adım Çözüm

1
Halt the procedure.
Immediate patient harm is prevented.
The primary duty of any physician is patient safety. An acutely impaired physician must not be allowed to perform clinical duties, especially high-risk procedures like intubation.
2
Secure alternate care.
The patient's emergent respiratory failure is treated.
Removing the impaired physician leaves a critically ill patient without care; securing a qualified replacement is the immediate secondary priority.
3
Notify institutional leadership.
Formal documentation and administrative protocols are activated.
Physicians are ethically obligated to report suspected impairment to appropriate clinical authorities to ensure the colleague receives help and future patients are protected.
4
Referral to a Physician Health Program.
The impaired physician undergoes formal evaluation and rehabilitation.
Institutional leaders are responsible for escalating the matter to specialized programs or licensing boards that manage physician substance use disorders.

Anahtar Kavram

Physician Impairment and Peer Reporting Sequence
Tahmini Süre:1m 30s
Soru 7Soru →

An emergency medical services team brings a 58-year-old man to the resuscitation bay due to progressive, profound weakness and an inability to stand. The patient's husband reports that the patient missed his last two hemodialysis appointments because of a local transportation strike. The patient has a known history of end-stage renal disease secondary to hypertensive nephrosclerosis, as well as type 2 diabetes mellitus. Upon arrival, he is lethargic but arousable. Vital signs include a blood pressure of 105/65 mmHg, a heart rate of 42/min, and a respiratory rate of 16/min. An immediate 12-lead electrocardiogram demonstrates marked sinus bradycardia with absent P waves, peaked T waves, and a widened QRS complex. A point-of-care basic metabolic panel reveals a serum potassium concentration of 7.8 mEq/L7.8 \text{ mEq/L}. The clinical team consults nephrology for emergent hemodialysis but determines that temporizing pharmacologic stabilization is required immediately. Arrange the following pharmacologic interventions in the most appropriate sequential order for this patient's acute management.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: Intravenous calcium gluconate, followed by Intravenous regular insulin and 50% dextrose, followed by Oral sodium zirconium cyclosilicate.
The management of severe hyperkalemia with electrocardiographic changes requires a strict, prioritized approach: stabilize the myocardium, shift potassium intracellularly, and eliminate potassium from the body. Intravenous calcium gluconate is the absolute first priority as it rapidly antagonizes the membrane effects of hyperkalemia, preventing fatal arrhythmias within minutes. Once the myocardium is stabilized, intracellular shifting agents like intravenous regular insulin (co-administered with dextrose to prevent hypoglycemia) are used to temporarily lower serum potassium over 15 to 30 minutes. Finally, agents that physically remove potassium from the body, such as oral sodium zirconium cyclosilicate, are administered; these are given last in the acute sequence because they take hours to exert their effect while definitive therapy (hemodialysis) is arranged.

Adım Adım Çözüm

1
Identify the life-threatening emergency.
The patient has severe hyperkalemia (7.8 mEq/L7.8 \text{ mEq/L}) with active cardiac toxicity evidenced by bradycardia, absent P waves, peaked T waves, and a widened QRS complex.
Recognizing electrocardiographic changes in the setting of extreme hyperkalemia dictates an immediate, protocol-driven pharmacologic sequence prior to definitive dialysis.
2
Prioritize myocardial stabilization.
Intravenous calcium gluconate is administered as the absolute first step.
Without immediate membrane stabilization, the patient is at imminent risk of deteriorating into ventricular fibrillation or asystole. Calcium acts within minutes.
3
Initiate intracellular potassium shifting.
Intravenous regular insulin (with dextrose to prevent hypoglycemia) is administered next.
Once the myocardium is protected, shifting potassium into cells temporarily lowers the dangerous extracellular concentration. This bridge therapy takes 15 to 30 minutes to work.
4
Initiate total body potassium elimination.
Oral sodium zirconium cyclosilicate is administered last among these choices.
While definitive removal requires hemodialysis for this anuric patient, gastrointestinal binders contribute to potassium elimination but have a delayed onset of several hours.

Anahtar Kavram

Stepwise pharmacologic management of severe hyperkalemia with electrocardiographic changes: 1) Stabilize myocardium, 2) Shift potassium intracellularly, 3) Eliminate potassium.
Tahmini Süre:1m 30s
Soru 8Soru →

A 68-year-old man with symptomatic, recurrent atrial fibrillation has failed rate control strategies and is planned for rhythm control with amiodarone. He has a history of coronary artery disease and heart failure with a left ventricular ejection fraction of 35%. You are planning his medication initiation and long-term follow-up. Arrange the following steps regarding the monitoring and treatment evaluation of this patient's amiodarone therapy in the correct chronological order, from baseline preparation to long-term surveillance.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: 1) Baseline organ function testing, 2) Acute ECG monitoring during loading, 3) 6-month thyroid and liver function surveillance, and 4) Annual pulmonary and ophthalmic screening.
Amiodarone is a highly effective antiarrhythmic, but it carries a massive burden of potential systemic toxicities due to its lipophilicity, high iodine content, and extremely long half-life. Safe management requires a strict temporal protocol: establishing baseline pulmonary, hepatic, and thyroid function; securing the acute loading phase against proarrhythmias; conducting 6-month interval checks for thyroid and hepatic dysfunction; and maintaining annual checks for chronic pulmonary or ocular damage.

Adım Adım Çözüm

1
Establish baseline clinical parameters prior to drug exposure.
Liver function tests, thyroid function tests, chest radiograph, and pulmonary function tests (including DLCO) are obtained.
Amiodarone causes multi-organ toxicity. Baseline values are essential to differentiate drug-induced injury from pre-existing disease progression.
2
Observe for acute electrical complications during the initial drug loading.
The patient is placed on continuous inpatient telemetry.
The loading phase carries the highest acute risk for severe bradycardia, AV block, and QT prolongation leading to Torsades de Pointes.
3
Implement mid-term surveillance for endocrine and hepatic side effects.
TSH and transaminases are drawn at 6 months.
Due to its high iodine content and lipophilicity, amiodarone can induce thyrotoxicosis, hypothyroidism, and hepatotoxicity, typically becoming apparent within the first 6 to 12 months.
4
Maintain long-term screening for chronic structural toxicities.
Annual chest radiograph and slit-lamp eye exam are scheduled.
Amiodarone pulmonary toxicity (APT) and ocular complications (corneal microdeposits, optic neuropathy) can present insidiously after years of therapy.

Anahtar Kavram

Standardized monitoring protocol for amiodarone toxicity
Soru 9Soru →

A 31-year-old man is brought to the emergency department by his partner due to severe confusion, high fever, and intractable vomiting for the past 12 hours. The partner reports that the patient was diagnosed with Graves disease two years ago but has been nonadherent to all medications for the past three months. Temperature is 40.1°C (104.2°F), pulse is 155/min, blood pressure is 162/68 mm Hg, and respirations are 26/min. Physical examination reveals a profusely diaphoretic and delirious patient. A prominent fine tremor is noted in the upper extremities. Neck examination reveals a diffusely enlarged, non-tender thyroid gland with an audible bruit. Electrocardiography demonstrates sinus tachycardia.

Arrange the following pharmacologic interventions in the strictly required chronological sequence for the acute management of this patient's condition.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is intravenous propranolol, followed by oral propylthiouracil, followed by potassium iodide solution.
The management of thyroid storm requires a strict sequence of pharmacologic interventions to prevent exacerbating the condition. Intravenous propranolol is given first to rapidly control severe sympathetic symptoms (e.g., tachycardia, hyperpyrexia, agitation) and reduce peripheral conversion of T4 to T3. Next, a thionamide such as propylthiouracil (PTU) is administered to halt the synthesis of new thyroid hormone. Finally, an iodine solution (such as potassium iodide) is given to block the release of preformed thyroid hormone (the Wolff-Chaikoff effect). The iodine must be given at least one hour after the thionamide to ensure synthesis is completely blocked; otherwise, the iodine will serve as a substrate and worsen the hyperthyroidism.

Adım Adım Çözüm

1
Administer intravenous propranolol
Rapid reduction in sympathetic overdrive and inhibition of peripheral T4 to T3 conversion
Immediate stabilization of cardiovascular status and control of adrenergic symptoms is the highest priority in thyroid storm.
2
Administer oral propylthiouracil (PTU)
Inhibition of thyroid peroxidase and blocking of new hormone synthesis
Synthesis of new thyroid hormone must be halted before exposing the hyperactive gland to a heavy iodine load.
3
Administer potassium iodide solution
Inhibition of preformed thyroid hormone release
Iodine must be given approximately 1 hour after PTU to prevent the iodine from being utilized as a substrate to produce more thyroid hormone.

Anahtar Kavram

Chronological pharmacologic sequence in the management of thyroid storm

Alternatif Yöntem

In patients with severe asthma or heart failure where non-selective beta-blockers like propranolol are contraindicated, alternative sympatholytic agents such as esmolol (cardioselective, short-acting) or diltiazem (calcium channel blocker) may be used as the first step.
Tahmini Süre:1m 0s
Soru 10Soru →

A 3838-year-old woman is evaluated in the clinic for progressive fatigue, weight gain, and cold intolerance over the past three months. Laboratory studies reveal a thyroid-stimulating hormone (TSH) level of 14.514.5 mIU/L (normal: 0.4−4.00.4-4.0 mIU/L) and a free thyroxine (T4) level of 0.60.6 ng/dL (normal: 0.9−1.70.9-1.7 ng/dL). She has no significant past medical history, takes no daily medications, and a urine pregnancy test is negative. She is diagnosed with primary hypothyroidism. Arrange the following steps in the correct chronological sequence regarding the initiation, monitoring, and evaluation of her thyroid hormone replacement therapy.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for monitoring and treatment evaluation in primary hypothyroidism begins with initiating weight-based levothyroxine, followed by checking TSH at 6 weeks, adjusting the dose as necessary, rechecking TSH 6 weeks after any adjustment, and finally transitioning to annual monitoring once a stable euthyroid state is achieved.
The management of primary hypothyroidism requires a stepwise approach to monitoring and treatment evaluation dictated by the pharmacokinetics of levothyroxine. The medication is initiated at a weight-based dose. Because it has a half-life of roughly 7 days, checking TSH before 4 to 6 weeks will yield an inaccurate assessment of the dose's efficacy. Therefore, the first TSH check is appropriately delayed to 6 weeks. If the TSH is not at goal, the dose is adjusted, which necessitates another 6-week waiting period to evaluate the new steady state. Once a patient is clinically and biochemically euthyroid on a stable dose, monitoring can safely be extended to annual intervals.

Adım Adım Çözüm

1
Initiate oral levothyroxine at a full replacement dose of approximately 1.6 mcg/kg daily.
The patient begins thyroid hormone replacement.
This is the standard starting step and dose for young, healthy adults without coronary artery disease.
2
Measure serum TSH levels 6 weeks after initiating therapy.
The initial steady-state TSH level is evaluated.
Levothyroxine has a 7-day half-life, so it takes 4-6 weeks to reach steady-state serum concentrations and accurately reflect pituitary suppression.
3
Adjust the levothyroxine dose by 12.5 to 25 mcg daily based on the initial follow-up TSH level.
The daily dose is optimized to target the normal TSH range.
If the initial TSH is not at goal, small incremental adjustments are necessary to prevent over- or under-replacement.
4
Repeat serum TSH measurement 6 weeks after the dose adjustment.
The effect of the new dose on the pituitary-thyroid axis is evaluated.
Just like the initial initiation, any dose adjustment requires another 4-6 week waiting period to reach a new steady state.
5
Transition to annual TSH monitoring once a stable, euthyroid maintenance dose is confirmed.
Long-term surveillance is established.
Once euthyroidism is achieved on a stable dose, the patient requires yearly checks to ensure the dose remains appropriate.

Anahtar Kavram

Chronological timeline for monitoring and evaluating levothyroxine replacement therapy based on medication pharmacokinetics.
Soru 11Soru →

A 42-year-old woman is evaluated in the clinic for fatigue and dyspnea on exertion. Laboratory testing reveals a microcytic anemia with a hemoglobin of 8.2 g/dL and a severely depressed serum ferritin. She is diagnosed with iron deficiency anemia secondary to heavy menstrual bleeding and is prescribed daily oral ferrous sulfate. To appropriately monitor the efficacy of her treatment, the physician considers the expected timeline of her hematologic recovery.

Arrange the following laboratory and clinical milestones in the chronological order they are expected to occur, from earliest (first) to latest (last), following the initiation of oral iron therapy.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence from earliest to latest is: Peak in the peripheral blood reticulocyte count -> Noticeable elevation in the hemoglobin concentration -> Complete normalization of the hemoglobin concentration -> Normalization of serum ferritin levels.
The physiological response to oral iron therapy follows a specific chronological sequence dictated by erythropoiesis and iron storage mechanisms. The bone marrow first responds by increasing red blood cell production, leading to a reticulocytosis that peaks at 7-10 days. This is followed by a gradual increase in hemoglobin, noticeable at 2-3 weeks, which eventually normalizes by 6-8 weeks. Finally, after the functional iron compartment (hemoglobin) is restored, excess iron is deposited in tissues, normalizing ferritin levels over 3-6 months.

Adım Adım Çözüm

1
Identify the earliest sign of bone marrow response to iron supplementation.
Peak in the peripheral blood reticulocyte count.
The bone marrow immediately utilizes the newly available iron for erythropoiesis, releasing immature red blood cells (reticulocytes) into the circulation. This peaks at 7 to 10 days.
2
Determine the timeline for initial improvement in the total red cell mass.
Noticeable elevation in the hemoglobin concentration.
As reticulocytes mature and more red blood cells are continuously produced, the hemoglobin level begins to rise measurably after 2 to 3 weeks.
3
Identify when the anemia is expected to be fully resolved.
Complete normalization of the hemoglobin concentration.
It takes approximately 6 to 8 weeks for sustained red blood cell production to fully correct the hemoglobin deficit and return it to the normal reference range.
4
Determine the final goal of monitoring therapy.
Normalization of serum ferritin levels.
Once the functional iron pool (hemoglobin) is restored, the body begins storing excess absorbed iron. Normalizing ferritin to replenish stores requires continuing iron therapy for 3 to 6 months after the anemia has resolved.

Anahtar Kavram

Timeline of hematologic response and iron store repletion when evaluating treatment efficacy for iron deficiency anemia.
Tahmini Süre:1m 0s
Soru 12Soru →

Paramedics bring a 58-year-old woman to the emergency department after her husband witnessed her suddenly collapse and begin shaking. Upon arrival in the resuscitation bay, she is actively experiencing a generalized tonic-clonic seizure. Her husband states the seizure activity has been continuous for approximately 15 minutes without any return to consciousness. She has no known past medical history and takes no daily medications. Vital signs show a blood pressure of 145/90 mmHg, heart rate of 118/min, and oxygen saturation of 94% on a non-rebreather mask. Intravenous access is rapidly established by the nursing staff, and a point-of-care blood glucose level is 102 mg/dL.

Arrange the following pharmacologic interventions in the correct sequential order for the management of this patient's condition, starting from the most immediate initial therapy to the final step for super-refractory disease.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: 1) Administer intravenous lorazepam, 2) Administer intravenous fosphenytoin, 3) Initiate a continuous intravenous propofol infusion, 4) Initiate a continuous intravenous pentobarbital infusion.
The management of status epilepticus follows a strict time-based protocol. The initial therapy phase (0-20 minutes) requires a rapid-acting benzodiazepine such as intravenous lorazepam. This is followed by the second therapy phase (20-40 minutes), which utilizes a non-benzodiazepine antiseizure medication such as fosphenytoin to achieve sustained control. If clinical or electrographic seizures continue, the patient enters refractory status epilepticus (40-60 minutes), necessitating intubation and continuous intravenous anesthetic infusions such as propofol. Finally, if seizures persist despite general anesthesia for 24 hours or more, it is termed super-refractory status epilepticus, and profound barbiturate coma with pentobarbital or thiopental is indicated as a last resort.

Adım Adım Çözüm

1
Identify the clinical emergency and the current duration of the event.
The patient is in generalized convulsive status epilepticus (continuous seizure >5 minutes, currently at 15 minutes).
Accurate diagnosis and timing dictate the specific phase of the treatment algorithm.
2
Select the first-line pharmacologic intervention.
Intravenous lorazepam is administered immediately.
Benzodiazepines are the most rapid and effective agents for acutely halting seizure activity in the initial phase (5-20 minutes).
3
Select the second-line pharmacologic intervention.
Intravenous fosphenytoin (or levetiracetam/valproic acid) is administered.
A long-acting non-benzodiazepine antiseizure medication must be given to prevent recurrence or to treat seizures that do not respond to the initial benzodiazepine (20-40 minute phase).
4
Determine the approach for refractory and super-refractory cases.
Propofol is used for refractory cases, followed by pentobarbital if super-refractory.
Anesthetic infusions like propofol or midazolam are used when standard agents fail. Pentobarbital induces a deep barbiturate coma and is strictly a last resort due to its severe hemodynamic side effects.

Anahtar Kavram

The stepwise, time-dependent pharmacologic management algorithm for generalized convulsive status epilepticus.
Soru 13Soru →

A 6565-year-old man is brought to the emergency department by emergency medical services after collapsing at an airport following a 1414-hour international flight. He has a history of end-stage renal disease and receives hemodialysis three times a week. On arrival, he is in severe respiratory distress, confused, and diaphoretic.

Vital signs are as follows:
- Temperature: 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F})
- Heart rate: 135/min135\text{/min}
- Blood pressure: 72/40 mmHg72/40\text{ mmHg}
- Respiratory rate: 32/min32\text{/min}
- Oxygen saturation: 82%82\% on room air

Physical examination reveals marked jugular venous distention and cyanosis of the distal extremities. Pulmonary auscultation is clear bilaterally. The physician suspects a massive pulmonary embolism causing acute obstructive shock.

Arrange the following diagnostic and therapeutic management steps in the most appropriate chronological sequence for this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for managing massive pulmonary embolism with hemodynamic instability in this patient begins with ABC stabilization, followed by hemodynamic support with vasopressors, bedside echocardiography for diagnosis, unfractionated heparin for anticoagulation (due to ESRD), and finally systemic thrombolysis.
The sequence for managing a massive pulmonary embolism begins with life-saving ABCs and hemodynamic support. Because the patient is unstable, transporting him for a CT pulmonary angiogram is contraindicated; therefore, bedside echocardiography is the appropriate next step to demonstrate right ventricular strain. Once confirmed, systemic anticoagulation is initiated. Notably, because this patient has end-stage renal disease, unfractionated heparin must be used instead of low-molecular-weight heparin to prevent drug accumulation and bleeding. Finally, definitive reperfusion with systemic thrombolytics (alteplase) is administered to dissolve the clot and relieve the obstructive shock.

Adım Adım Çözüm

1
Administer high-flow supplemental oxygen and establish large-bore intravenous access.
Hypoxemia is addressed and a route for emergency medications is secured.
Securing the airway and providing supplemental oxygen mitigates hypoxic pulmonary vasoconstriction, which would otherwise worsen right ventricular strain.
2
Initiate intravenous vasopressor therapy to target a mean arterial pressure >65 mmHg> 65\text{ mmHg}.
Perfusion to vital organs, including the coronary arteries, is maintained.
Hypotension in massive pulmonary embolism rapidly leads to right ventricular ischemia and cardiovascular collapse; immediate hemodynamic support is essential.
3
Perform bedside point-of-care echocardiography to evaluate for right ventricular dysfunction.
Right ventricular dilation and hypokinesis are identified.
An unstable patient cannot safely travel to a CT scanner. Point-of-care echocardiography is the diagnostic modality of choice to confirm the suspected diagnosis.
4
Initiate systemic anticoagulation with intravenous unfractionated heparin.
Further propagation of the thromboembolism is halted.
Systemic anticoagulation must be initiated promptly. Low-molecular-weight heparins (like enoxaparin) are contraindicated in end-stage renal disease, necessitating the use of unfractionated heparin.
5
Administer intravenous alteplase for definitive systemic thrombolytic therapy.
The pulmonary arterial clot burden is rapidly reduced, restoring forward blood flow.
Once right heart strain is confirmed and baseline anticoagulation is addressed, thrombolytics are administered to break down the existing clot and resolve the obstructive shock.

Anahtar Kavram

Management of massive pulmonary embolism involves immediate stabilization, bedside echocardiography, and systemic thrombolysis, with unfractionated heparin preferred over low-molecular-weight heparin in patients with severe renal impairment.
Tahmini Süre:1m 30s
Soru 14Soru →

A 2222-year-old man with type 1 diabetes mellitus is being treated in the intensive care unit for diabetic ketoacidosis. He has been receiving a continuous intravenous regular insulin infusion, intravenous fluids, and potassium replacement for the past 1414 hours. Current laboratory evaluation reveals a blood glucose of 178178 mg/dL, a serum bicarbonate of 2020 mEq/L, and a calculated anion gap of 99 mEq/L. The patient is awake, alert, and reports feeling hungry. The physician decides to transition the patient to a subcutaneous insulin regimen. Arrange the following management and monitoring steps in the correct chronological sequence to safely accomplish this therapeutic de-escalation.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with verifying diabetic ketoacidosis resolution, followed by administering subcutaneous basal insulin, maintaining an overlap with the intravenous insulin for 11 to 22 hours, discontinuing the intravenous infusion, and finally initiating routine preprandial monitoring.
The successful treatment of diabetic ketoacidosis requires a carefully monitored transition from continuous intravenous insulin to intermittent subcutaneous insulin. The protocol dictates that the physician must first confirm resolution of the ketoacidosis (anion gap ≤12\leq 12 mEq/L) and ensure the patient can tolerate oral intake. Because intravenous insulin clears the body within minutes and subcutaneous insulin takes 11 to 22 hours to begin working, subcutaneous basal insulin must be administered while the intravenous infusion is still running. This 11 to 22 hour overlap is critical to prevent a gap in insulin coverage, which would cause rapid rebound ketoacidosis. Only after this overlap period is complete should the intravenous infusion be discontinued. Finally, the patient is transitioned to routine maintenance monitoring, typically involving blood glucose checks before meals and at bedtime.

Adım Adım Çözüm

1
Assess clinical and laboratory criteria for diabetic ketoacidosis resolution.
The anion gap is closed (99 mEq/L) and the patient is able to eat.
Ensures that transitioning off continuous insulin is safe and physiologically appropriate.
2
Administer subcutaneous long-acting basal insulin.
A long-acting insulin depot is established in the subcutaneous tissue.
Provides baseline insulin coverage to prevent rebound hyperglycemia.
3
Overlap the intravenous and subcutaneous insulin for 11 to 22 hours.
Continuous insulin coverage is maintained during subcutaneous absorption.
Subcutaneous insulin takes time to reach systemic circulation and take effect.
4
Stop the continuous intravenous regular insulin infusion.
The patient is completely transitioned to subcutaneous insulin.
Intravenous insulin is no longer needed once the subcutaneous depot is active.
5
Transition to standard inpatient glycemic monitoring.
Blood glucose is checked before meals and at bedtime.
Allows for ongoing monitoring and administration of short-acting nutritional/correctional insulin.

Anahtar Kavram

Therapeutic De-escalation Protocol for Diabetic Ketoacidosis
Soru 15Soru →

A 68-year-old man is preparing for discharge to a subacute rehabilitation facility following a prolonged hospitalization for acute decompensated heart failure and superimposed hospital-acquired pneumonia. His clinical course necessitated numerous changes to his baseline diuretic, antihypertensive, and diabetic regimens. The discharging physician is executing the formal medication reconciliation process to ensure safe continuity of care and prevent adverse drug events during this care transition. Arrange the following fundamental steps of the standardized medication reconciliation process in the correct chronological sequence.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence for medication reconciliation is: 1) Acquire pre-admission history, 2) Review inpatient medications, 3) Cross-reference lists for discrepancies, 4) Resolve discrepancies clinically, and 5) Transmit the finalized regimen.
The Institute for Healthcare Improvement (IHI) and The Joint Commission mandate a standardized 5-step medication reconciliation process during transitions of care. The chronological process must strictly begin with obtaining the Best Possible Medication History (pre-admission list), followed by reviewing the current hospital medications. These two independent lists are then systematically cross-referenced to identify discrepancies (e.g., missing chronic medications, unintended duplications). The physician then uses clinical judgment to resolve these discrepancies and create a definitive discharge list. Finally, this accurate, finalized list must be formally communicated to the receiving facility (or primary care provider) and the patient to ensure safe continuity of care.

Adım Adım Çözüm

1
Establish the patient's baseline regimen.
Creation of the Best Possible Medication History (pre-admission list).
It is impossible to identify medication omissions or unintended changes without knowing the exact starting point.
2
Identify all current acute therapies.
Compilation of the inpatient medication list.
This is necessary to understand what therapies were added, discontinued, or modified during the hospitalization.
3
Compare the baseline list with the acute therapy list.
Identification of any medication discrepancies.
This systematic comparison highlights unintended omissions of chronic medications or inappropriate continuations of acute-only treatments.
4
Apply clinical decision-making to the discrepancies.
Formulation of the finalized discharge medication regimen.
Ensures that the final list is medically appropriate for the patient's current post-acute stability and ongoing chronic needs.
5
Communicate the final regimen to the next care setting.
Safe transition of care and implementation of the correct treatments.
Prevents administration errors, adverse drug events, and readmissions caused by communication failures at the receiving facility.

Anahtar Kavram

Medication reconciliation during care transitions is a structured, standardized five-step process designed to prevent adverse drug events by systematically identifying and resolving medication discrepancies before patient handoffs.
Soru 16Soru →

A 2828-year-old man is admitted to the intensive care unit with diabetic ketoacidosis. He is initially started on a continuous intravenous regular insulin infusion and 0.9%0.9\% normal saline. Over the next several hours, his blood glucose decreases from 550550 mg/dL to 220220 mg/dL. However, his calculated anion gap remains elevated at 1818 mEq/L, and his serum bicarbonate is 1414 mEq/L. He is clinically stable, and his mental status is improving.

Arrange the following subsequent management and monitoring steps in the correct chronological order to safely resolve the ketoacidosis and transition his therapy.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to first add dextrose to the IV fluids, then verify resolution of the anion gap, administer subcutaneous insulin, maintain a 11- to 22-hour overlap with the IV insulin, and finally discontinue the IV insulin.
The chronological management of diabetic ketoacidosis (DKA) focuses first on clearing ketoacids, which requires continuous insulin. When glucose falls below 200200-250250 mg/dL but the anion gap remains elevated, dextrose must be added to the IV fluids so insulin can be continued without causing hypoglycemia. Once the anion gap closes (≤12\leq 12 mEq/L), DKA is considered resolved. At this point, if the patient can tolerate oral intake, subcutaneous insulin is administered. Because IV insulin has a half-life of only a few minutes and subcutaneous insulin requires 11-22 hours for systemic absorption, the IV infusion must be continued for a 11- to 22-hour overlap period. Only after this overlap can the IV insulin be safely discontinued. Failing to overlap correctly is a major cause of rebound DKA in the hospital setting.

Adım Adım Çözüm

1
Evaluate the current metabolic parameters and adjust intravenous fluids.
Recognize that blood glucose has dropped below 250250 mg/dL but ketoacidosis persists (anion gap >12> 12 mEq/L). Dextrose is added to the IV fluids to prevent hypoglycemia while maintaining the insulin drip.
Continuous insulin is required to halt lipolysis and clear ketones; it cannot be stopped or significantly decreased based solely on glucose levels.
2
Monitor serial laboratory values until metabolic resolution is achieved.
Confirm that the anion gap has closed (≤12\leq 12 mEq/L) and bicarbonate has normalized (≥15\geq 15 mEq/L).
This indicates the underlying ketoacidosis has resolved, allowing for the safe transition to maintenance therapy.
3
Initiate the transition to subcutaneous insulin.
Administer a dose of long-acting subcutaneous basal insulin.
Subcutaneous insulin must be on board before the IV insulin is withdrawn to maintain basal metabolic control.
4
Overlap therapies to ensure continuous insulin coverage.
Continue the IV regular insulin infusion for 11 to 22 hours after the subcutaneous injection.
Subcutaneous insulin has a delayed onset of action. An overlap prevents a period of absolute insulin deficiency that could trigger rebound ketoacidosis.
5
Finalize the transition.
Discontinue the IV regular insulin infusion.
The subcutaneous insulin has now reached therapeutic levels, providing safe and continuous coverage.

Anahtar Kavram

Successful management of diabetic ketoacidosis requires maintaining an insulin infusion until the anion gap closes (adding dextrose if glucose falls prematurely) and ensuring a 11- to 22-hour overlap when transitioning to subcutaneous insulin to prevent rebound ketoacidosis.
Soru 17Soru →

A 62-year-old man is brought to the emergency department by emergency medical services (EMS) due to the sudden onset of difficulty breathing, facial swelling, and a diffuse pruritic rash. The symptoms began 15 minutes ago while he was eating at a seafood restaurant. His medical history is significant for hypertension, coronary artery disease, and heart failure with preserved ejection fraction. His home medications include lisinopril, metoprolol, aspirin, and atorvastatin. Upon arrival, his blood pressure is 74/40 mm Hg, pulse is 62/min, and oxygen saturation is 90% on room air. Physical examination reveals marked angioedema of the lips, widespread urticaria, and diffuse bilateral expiratory wheezing. EMS has established peripheral intravenous access.

Arrange the following pharmacologic interventions in the correct sequential order of administration for the acute escalation of therapy in this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: 1) Administer intramuscular epinephrine, 2) Administer a rapid intravenous bolus of 0.9% sodium chloride, 3) Administer intravenous glucagon, 4) Initiate a continuous intravenous epinephrine infusion.
The correct sequential management for severe anaphylactic shock in a patient taking beta-blockers follows a distinct escalation pathway. First, intramuscular epinephrine is the absolute first-line therapy and must never be delayed. Second, for persistent hypotension, aggressive intravenous fluid resuscitation with isotonic crystalloids (0.9% sodium chloride) is the next immediate step to counteract massive vasodilation and capillary leak. Third, because this patient is on metoprolol, his beta-adrenergic receptors are blocked, which can render standard epinephrine less effective (evidenced by his lack of compensatory tachycardia). In such refractory cases, intravenous glucagon is administered because it increases intracellular cAMP and provides inotropic and chronotropic effects independent of beta-receptors. Finally, if the patient remains in shock despite these interventions, a continuous intravenous epinephrine infusion is initiated to maintain perfusion.

Adım Adım Çözüm

1
Diagnose the acute condition based on the clinical presentation.
The patient is experiencing severe anaphylactic shock.
Sudden onset of dyspnea, angioedema, urticaria, wheezing, and profound hypotension after allergen exposure (seafood) confirm anaphylaxis.
2
Identify the critical home medication influencing the presentation.
The patient is taking metoprolol, a beta-blocker.
The relative bradycardia (pulse 62/min) in the setting of severe distributive shock suggests beta-blockade, which blunts the compensatory tachycardic response and can render standard epinephrine doses ineffective.
3
Select the immediate first-line pharmacologic intervention.
Administer intramuscular epinephrine.
Intramuscular epinephrine is the life-saving first step for all anaphylaxis patients to halt mast cell degranulation, regardless of concurrent beta-blocker use.
4
Determine the next step for persistent distributive shock.
Administer a rapid intravenous bolus of 0.9% sodium chloride.
Aggressive fluid resuscitation is required to counteract the massive capillary leak and vasodilation that occurs in anaphylaxis.
5
Select the specific antidote for beta-blocker-associated refractory anaphylaxis.
Administer intravenous glucagon.
Glucagon bypasses the blocked beta-adrenergic receptors to increase intracellular cAMP, providing essential inotropic and chronotropic support as well as bronchodilation.
6
Identify the final escalation step if the patient remains in shock.
Initiate a continuous intravenous epinephrine infusion.
When intermittent intramuscular doses, fluids, and glucagon fail to restore perfusion, a continuous vasopressor infusion is necessary.

Anahtar Kavram

The correct escalation sequence for managing refractory anaphylaxis in a patient on beta-blockers is intramuscular epinephrine, followed by intravenous fluid resuscitation, intravenous glucagon, and finally continuous intravenous epinephrine infusion.
Tahmini Süre:1m 30s
Soru 18Soru →

An octogenarian patient with a history of moderate dementia is medically stable for discharge following a prolonged admission for urosepsis. During the hospital course, the patient experienced severe deconditioning and is now unable to perform basic mobility tasks without maximal physical assistance. The primary inpatient team determines that the patient requires transition to a skilled nursing facility (SNF) to receive structured physical therapy and skilled nursing oversight. To ensure a compliant and safe care transition that minimizes readmission risk, arrange the following multidisciplinary and physician actions in the correct chronological sequence.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with assessing specific clinical needs, followed by verifying payer eligibility, selecting a facility with the surrogate, transmitting records for acceptance, and concluding with a clinician-to-clinician handoff.
A safe and compliant care transition follows a systematic workflow. First, the clinical team must assess the patient to identify specific skilled needs. Next, case management verifies that these needs and the hospital course meet payer criteria for post-acute coverage. Once eligibility is confirmed, the healthcare proxy is engaged to select preferred facilities based on location and capability. Clinical records are then sent to these selected facilities so their medical directors can approve the admission. Finally, once a bed is secured and transfer is pending, the discharging physician conducts a direct verbal handoff with the receiving clinician to ensure continuity of care.

Adım Adım Çözüm

1
Assess post-acute skilled needs via the multidisciplinary team.
Clinical requirements for placement (e.g., daily PT/OT, nursing needs) are clearly delineated.
Establishes the medical necessity required to initiate the disposition planning process.
2
Verify regulatory and payer eligibility.
Confirmation that the patient qualifies financially and legally for the SNF level of care.
Prevents inappropriate referrals that would result in out-of-pocket costs or denial of care.
3
Engage the proxy for facility selection.
A targeted list of preferred, in-network facilities is created.
Ensures shared decision-making and respects family preferences for care locations once eligibility is known.
4
Transmit clinical documentation to selected facilities.
Receiving facilities review the patient's case and provide formal medical acceptance.
SNFs are legally required to review recent notes to confirm they have the clinical capacity to manage the patient safely.
5
Perform clinician-to-clinician verbal handoff.
Active issues, pending labs, and care nuances are communicated directly.
Minimizes medical errors and ensures continuity of care during the physical transfer.

Anahtar Kavram

Safe disposition to a post-acute care facility requires a systematic workflow: identifying specific care needs, verifying regulatory eligibility, shared facility selection, obtaining formal medical acceptance, and finalizing with a direct clinical handoff.
Soru 19Soru →

A 68-year-old man is admitted to the inpatient palliative care unit due to progressive, severe dyspnea. He has stage IV non-small cell lung cancer with extensive pleural involvement and lymphangitic carcinomatosis. He is currently awake but visibly distressed, breathing at 32 breaths per minute. His oxygen saturation is 89% on room air. The patient has a 'Do Not Resuscitate / Do Not Intubate' (DNR/DNI) order in place, and his stated primary goal of care is maximum comfort.

Arrange the following interventions in the appropriate stepwise order of escalation for the management of this patient's terminal dyspnea, from the initial step to the final step for refractory symptoms.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The appropriate stepwise escalation for terminal dyspnea begins with non-pharmacologic measures, proceeds to enteral opioids, escalates to continuous parenteral opioids, and utilizes palliative sedation only as a last resort.
The standard approach to managing dyspnea at the end of life follows a stepwise escalation. Non-pharmacologic measures are the foundation. When pharmacotherapy is needed, opioids are the treatment of choice, starting with intermittent oral or sublingual doses. For persistent or severe symptoms, continuous parenteral infusions are used. Palliative sedation is strictly reserved for refractory symptoms when all other measures fail.

Adım Adım Çözüm

1
Implement non-pharmacologic interventions.
Bedside fan and positioning applied.
Provides immediate, non-invasive relief by stimulating trigeminal nerve receptors and reducing the work of breathing.
2
Initiate first-line pharmacologic therapy.
Oral or sublingual morphine administered.
Opioids are the gold standard for treating dyspnea in advanced illness, acting to decrease central respiratory drive and alter the perception of breathlessness.
3
Escalate the opioid delivery method if symptoms persist.
Continuous intravenous or subcutaneous opioid infusion started.
Parenteral continuous delivery ensures steady-state relief for severe, progressive dyspnea that is unresponsive to intermittent dosing.
4
Consider therapy of last resort for refractory symptoms.
Palliative sedation with midazolam initiated.
Used exclusively when dyspnea remains unbearable despite maximal optimal opioid therapy, aiming to lower consciousness to relieve suffering.

Anahtar Kavram

Stepwise management of terminal dyspnea in palliative care
Soru 20Soru →

A physician is preparing to discuss recent imaging findings with a 59-year-old man and his spouse. The patient underwent a computed tomography scan of the chest due to chronic cough and weight loss, which revealed a large spiculated pulmonary mass with mediastinal lymphadenopathy, highly suspicious for advanced malignancy. The physician plans to deliver this information using the SPIKES protocol. Arrange the following physician statements in the correct chronological sequence to appropriately execute this framework.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence for the SPIKES protocol is: 1) Assessing the patient's understanding, 2) Asking for permission regarding detail level, 3) Disclosing the diagnosis, 4) Responding to emotional distress empathetically, and 5) Formulating a follow-up plan.
The SPIKES protocol is a standard, structured approach for delivering bad news. It consists of six steps: Setting up the interview (implied in the stem), assessing the patient's Perception, obtaining the patient's Invitation, giving Knowledge, addressing Emotions with empathic responses, and establishing a Strategy/Summary. The correct chronological sequence requires the physician to first gauge what the patient already suspects (Perception), then ask how much detail they desire (Invitation). Only then should the physician deliver the diagnosis, preceded by a warning phrase (Knowledge). Following the disclosure, the physician must prioritize responding to the patient's affective state with validation and empathy (Emotion) before finally establishing a concrete medical plan for the future (Strategy).

Adım Adım Çözüm

1
Identify the communication framework required for this clinical scenario.
The scenario involves disclosing a highly suspicious malignancy, which requires the SPIKES protocol for delivering bad news.
Structured frameworks like SPIKES reduce patient anxiety and improve physician confidence during difficult conversations.
2
Identify the first required action among the provided statements.
The statement assessing the patient's current understanding ('Before we discuss the CT scan results...') is selected.
This aligns with 'Perception' (P), allowing the physician to correct misinformation and tailor the subsequent dialogue.
3
Select the statement that establishes the patient's information preferences.
The statement asking how much detail is desired ('Would you like me to go over all the specific details...') is chosen.
This aligns with 'Invitation' (I), ensuring the physician respects the patient's right to know or not know specific details.
4
Identify the statement that formally delivers the diagnosis.
The statement providing the scan findings with a warning phrase ('I am afraid the scan results are concerning...') is selected.
This aligns with 'Knowledge' (K), delivering the medical truth clearly and without confusing jargon.
5
Select the most appropriate immediate response to the delivered bad news.
The statement offering empathy ('I can see that this is a tremendous shock...') is chosen.
This aligns with 'Emotions' (E), validating the patient's psychological distress before moving on to clinical logistics.
6
Identify the concluding statement that outlines the next steps.
The statement regarding scheduling a biopsy ('When you are ready, we can talk about scheduling...') is selected.
This aligns with 'Strategy and Summary' (S), establishing a concrete follow-up plan so the patient does not feel abandoned.

Anahtar Kavram

Applying the SPIKES communication protocol for delivering bad news
Tahmini Süre:2m 0s
Sayfa 1 / 39Sonraki
Tüm alıştırma soruları — USMLE Step 3 | Examkin